We found a significant reduction of stroma-mediated protection from apoptosis in CLL 014 cells when stromal vimentin was competitively blocked by the CLL BCR or a commercially available anti-vimentin antibody and found an enhanced protective effect when feeder cells were forced to secrete vimentin. Here, BCR is linked to B-cell chronic lymphocytic leukemia.